Inserm's October 2026 review clarifies the medical evidence behind menopause coaching, supplements and testosterone, separating clinical facts from marketing.
On 1 October 2026, the French biomedical research agency Inserm published a Canal Detox article examining the medical evidence behind menopause coaching, supplements, testosterone and cooling devices. The review evaluates these consumer options alongside established clinical treatments to clarify what actually relieves symptoms.
For years, the standard approach to perimenopause and menopause relied heavily on direct clinical consultation for severe hot flashes. The clinical space once clearly distinguished between verified medical interventions and general wellness advice. Doctors provided targeted relief for severe symptoms while ignoring unproven alternative products. Recently, a massive wave of commercial wellness products entered the market and aggressively targeted midlife women.
This sudden shift created an environment where marketing claims were frequently mistaken for medical evidence. Women were often left to navigate a confusing landscape of digital apps, natural supplements and off-label testosterone promises without clear clinical guidance. The new Inserm review directly challenges this blurred line between established medical care and consumer wellness. It reasserts strict evidence standards for managing midlife physical transitions and symptom relief.
The publication reinforces that treatment choices should be individualized by a qualified clinician rather than assumed from advertising. It clearly separates proven medical therapies from early, mixed or commercially promoted claims. Clinicians are now urged to actively guide patients away from unsupported wellness hype.
Inserm’s assessment provides a practical framework for women evaluating their health options. The article attributes its clinical review to two medical gynecology specialists with menopause care roles at university hospitals. Florence Trémollières and Valérie Bernard helped establish clear boundaries for evidence-based care. The agency details several critical updates regarding menopause interventions:
The wellness industry frequently promotes plant-based supplements as risk-free alternatives to medical treatments. Women are routinely encouraged to try soy isoflavones or red clover extracts to manage their daily symptoms. Marketing campaigns often position these botanical options as highly effective remedies for the hormonal transition. Inserm clarifies that natural is simply a description rather than a guarantee of safety or clinical efficacy.
The reported benefits of these phytoestrogens are highly inconsistent and not found across all published studies. These supplements should never replace a thorough clinical evaluation by a medical professional. Women must explicitly avoid phytoestrogen supplements if they have a history of hormone-dependent cancer. Relying on inconsistent botanical extracts can delay access to much more effective therapeutic options.
Patients spend significant amounts of money on products that offer only marginal or unproven benefits. Discussing targeted symptom relief with a knowledgeable clinician provides a much safer path forward.
Hormone clinics and wellness centers increasingly promote testosterone as a cure for midlife energy loss. Many patients are told it will effortlessly restore their metabolism, memory and youthful physical appearance. Inserm strongly counters this narrative by citing the 2019 Global Consensus Position Statement on the Use of Testosterone Therapy for Women. The evidence simply does not support using testosterone for hot flashes, fatigue or changes in body composition and metabolism.
Treating testosterone as a universal anti-aging tool is fundamentally unsupported by current medical science. The only established benefit for postmenopausal women concerns a very specific clinical diagnosis. Inserm identifies hypoactive sexual desire disorder accompanied by personal or relationship distress as the sole demonstrated indication. If testosterone is suggested for general fatigue or memory issues, patients should ask the prescriber to explain the medical evidence.
Addressing complex issues with sexual wellbeing and intimate confidence requires professional evaluation rather than aggressive self-treatment. Using testosterone products marketed for men without dose adjustment can lead to permanent physical changes. These risks include severe acne, uncontrolled hair loss and sometimes lasting vocal alterations. Careful medical monitoring remains a strict requirement for patient safety.
The digital health market has recently flooded consumers with coaching programs and menopause tracking applications. These technological tools promise to guide women through their hormonal transition with customized algorithmic advice. Commercial platforms often present their guidance as equivalent to professional medical care. Inserm explicitly warns that these consumer services are highly variable in quality and factual accuracy.
Some programs draw on validated clinical recommendations while others offer completely scientifically unsupported information. A comprehensive analysis revealed that only a small minority of these apps actually involve health professionals. Many platforms rely entirely on user-generated data without any formal clinical oversight or verification. These digital tools should function exclusively as a supplement to professional medical advice.
They can help track symptom patterns for a doctor visit but cannot diagnose underlying medical conditions. Making healthcare decisions based on unverified app recommendations carries unnecessary physical risks. Before spending money on a digital application or coaching program, women should ask what specific evidence supports the service. They should demand total transparency about the active involvement of qualified health professionals.
For bothersome hot flashes, a clinician can help compare hormone therapy and nonhormonal options in light of specific symptoms. The clinical decision process must carefully account for patient preferences, medical history and individual contraindications. Inserm clearly describes menopausal hormone therapy as the most effective treatment for hot flashes. However, this established effectiveness does not make it a universal answer for every midlife health concern.
The therapy requires careful calibration to match a woman's unique physiological profile. An individualized approach using transdermal estradiol offers highly targeted relief for severe vasomotor symptoms. Prescribing must happen on a strict case-by-case basis after a thorough physical health evaluation. Inserm recommends using progesterone alongside estradiol for women who still have a uterus.
Women navigating midlife health transitions deserve comprehensive treatments backed by robust scientific evidence. This personalized therapeutic strategy allows patients to maintain their physical capabilities safely over time.
Women who cannot or do not want to use hormones have access to alternative medical options. The recent introduction of fezolinetant in France provides a novel nonhormonal pathway for managing severe symptoms. However, Inserm strongly highlights that the label non-hormonal does not translate to being risk-free or monitoring-free. Patients considering this specific medication must undergo liver monitoring before and during the entire treatment course.
Ignoring these monitoring requirements can expose women to potential liver injury risks. The medical review also acknowledges the potential supplementary role of complementary lifestyle approaches. Inserm mentions hypnosis, yoga and acupuncture as therapeutic interventions with modest reported effects. These accessible practices can support overall physical wellbeing without carrying the severe side effects of unmonitored hormone use.
Cooling bandanas, personal fans and connected ice cubes are often marketed as high-tech solutions for hot flashes. Inserm firmly states there is no clear demonstrated effect on symptom frequency to justify their routine clinical recommendation. Focusing exclusively on proven medical therapies saves valuable time, money and emotional frustration.
A typical menopause transition requires practical context rather than heightened symptom panic. The hormonal changes affecting women between 38 and 65 are natural expected biological processes. Identifying these changes clinically allows women to make highly informed decisions about their long-term bodily health. A skilled doctor can help separate actual hormonal shifts from other age-related physiological changes.
This clarity prevents women from pursuing unnecessary or unproven commercial wellness treatments. Women should clearly articulate their most bothersome physical symptoms during every medical consultation. This focused communication helps clinicians determine whether hormone therapy, nonhormonal medication or lifestyle adjustments are appropriate. Understanding the robust evidence behind each option truly empowers patients to decline unproven commercial treatments.
The goal is always to improve daily function rather than chase unrealistic anti-aging promises. It is completely reasonable to expect credible detailed explanations from your primary healthcare provider. Refusing to settle for social media slogans or rushed clinical appointments is a critical part of self-advocacy. Medical care should always treat midlife women as capable adults rather than anxious anti-aging consumers.
Going forward, this research dictates that clinical practice must increasingly prioritize individualized symptom management and strict evidence standards over generalized commercial marketing.
Understanding the measurable impact of treatments on changes in strength, muscle, body composition, metabolism or weight requires separating medical facts from commercial marketing. We address the confusion about which midlife changes are hormonal and which have multiple causes, translating credible evidence into clear adult guidance without anti-aging pressure so you can make informed choices about your physical transition.
Follow Refemina for research-led insights on menopause, strength, metabolism, nutrition, skin, intimacy and confidence through midlife. New articles turn complex topics into clear, useful context.
Keep learning about the changes that shape energy, strength, confidence and wellbeing through midlife.
Explore Resources